FDA Moves to Reevaluate Several Peptides American Med Spa Association A Turning Point for Peptides? What RFK Jr.'s Announcement Could Mean for the Future of Wellness and Longevity Skytale Group An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Everything You Need to Know About the FDA Peptide Ban